Carson Wealth (CWM LLC)’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
20,379
-5,572
-21% -$183K ﹤0.01% 1916
2025
Q4
$971K Buy
25,951
+18,449
+246% +$607K ﹤0.01% 1515
2025
Q3
$207K Buy
7,502
+5,075
+209% +$175K ﹤0.01% 2414
2025
Q2
$77K Sell
2,427
-277
-10% -$8.91K ﹤0.01% 2931
2025
Q1
$90K Buy
2,704
+698
+35% +$25K ﹤0.01% 2504
2024
Q4
$69K Buy
2,006
+537
+37% +$18.5K ﹤0.01% 2544
2024
Q3
$59K Buy
1,469
+775
+112% +$27.2K ﹤0.01% 2567
2024
Q2
$21K Buy
694
+247
+55% +$7.43K ﹤0.01% 3077
2024
Q1
$15K Buy
447
+339
+314% +$10.9K ﹤0.01% 3095
2023
Q4
$3K Sell
108
-118
-52% -$3.29K ﹤0.01% 3699
2023
Q3
$7K Buy
226
+122
+117% +$4.24K ﹤0.01% 3298
2023
Q2
$4K Buy
104
+7
+7% +$242 ﹤0.01% 3528
2023
Q1
$3K Buy
97
+2
+2% +$91 ﹤0.01% 3509
2022
Q4
$5K Buy
95
+9
+10% +$495 ﹤0.01% 3180
2022
Q3
$4K Buy
+86
New +$4.2K ﹤0.01% 3176
2022
Q2
Sell
-30
Closed -$1K 3924
2022
Q1
$1K Buy
+30
New +$1.22K ﹤0.01% 3350

Other funds holding HRMY

Carson Wealth (CWM LLC)'s HRMY Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Harmony Biosciences (HRMY) stake by 21% in Q1 2026, selling an estimated $183K and leaving 20,379 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

Carson Wealth (CWM LLC) first reported a position in HRMY in Q1 2022 and has held it in 16 quarters since. The position peaked at $971K in Q4 2025. 310 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Carson Wealth (CWM LLC) held 20,379 shares of Harmony Biosciences worth $571K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 5,572 Harmony Biosciences shares in Q1 2026, an estimated $183K.
  • Harmony Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1916 holding.
  • Carson Wealth (CWM LLC) first reported a position in Harmony Biosciences in Q1 2022 and has held it in 16 quarters since.
  • Carson Wealth (CWM LLC)'s Harmony Biosciences position peaked at $971K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.